Early antibiotic use increases diabetes risk later

Recent research suggests that early exposure to antibiotics may increase the risk of developing diabetes later in life. This study, conducted on mice, indicates that antibiotics can hinder the growth of insulin-producing cells in the pancreas during a critical time in infancy. The findings were published in the journal Science. The study highlights the importance of the infant microbiome, a collection of microorganisms that play a role in early development. Researchers believe this information could lead to new methods for managing metabolic diseases. Type 1 diabetes affects over 2 million adults in the U.S. It occurs when the pancreas does not produce enough insulin, resulting in high blood sugar levels. Genetics play a role, but environmental factors also influence whether someone develops the disease. Previous research shows that infants who are breastfed or born vaginally tend to have a healthier microbiome and are less likely to get Type 1 diabetes. However, administering antibiotics can disrupt this balance. The current study focused on identifying which microbes are essential for healthy pancreatic cell development. Researchers found that exposing mice to broad-spectrum antibiotics at a specific age, similar to 7 to 12 months in human infants, led to fewer insulin-producing cells and worse metabolic health in adulthood. This highlights the critical period for microbial development. In additional experiments, scientists found that introducing certain microbes helped mice produce more beta cells. One beneficial fungus, Candida dubliniensis, was particularly effective. Mice that received this fungus during infancy showed significantly lower rates of diabetes later on. The study used fecal samples from healthy infants to create "poop slushies," which were given to newborn mice. The results indicated that specific microbes are crucial for healthy beta cell growth. Despite these promising findings, the researchers caution that it is too early for new treatments based on this research. Hill emphasizes that she is not against antibiotics but hopes for future solutions that could replace lost microbes during antibiotic treatment. The research may lead to new strategies that use beneficial microbes to help restore pancreatic function and combat diabetes. Hill has also established a facility for studying the infant microbiome to explore how these microbes can support health. She believes understanding the role of beneficial microorganisms can significantly improve human health outcomes.